News & Events

Authors

Related Practice Areas

Media Contact

Diana L. Courson
202.778.1871

Trump’s new FDA commissioner has a huge decision to make

May 16, 2017
William B. Schultz
The Washington Post

Partner Bill Schultz wrote an Op-Ed for The Washington Post about marketing off-label uses of prescription drugs and other decisions facing new FDA Commissioner Scott Gottlieb.

Read the full op-ed here.

Offices